BREAST-CANCER - CHEMOTHERAPY IN THE TREATMENT OF ADVANCED DISEASE

被引:31
作者
CLAVEL, M
CATIMEL, G
机构
[1] Centre Léon Bérard, 69373 Lyon Cedex 08, 28, rue Laennec
关键词
D O I
10.1016/S0959-8049(05)80161-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemotherapy in patients with advanced breast cancer remains palliative. Although the majority of patients will experience an initial response or stabilisation of the disease, the survival is only modestly improved. The search for new drugs and more effective combinations must therefore continue. High-dose chemotherapy with or without autologous bone marrow transplant (ABMT) is an enthusiastic perspective of progress but the available data do not permit conclusions about the effectiveness of high-dose therapy compared with conventional treatment.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 96 条
[1]  
ABOUD A, 1983, P AM SOC CLIN ONCOL, V2, P107
[2]  
AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P877
[3]  
AHMANN FR, 1987, CANCER, V59, P239, DOI 10.1002/1097-0142(19870115)59:2<239::AID-CNCR2820590211>3.0.CO
[4]  
2-C
[5]   CHEMOTHERAPY VERSUS CHEMOIMMUNOTHERAPY (CAF V CAFVP V CMF EACH +/- MER) FOR METASTATIC CARCINOMA OF THE BREAST - A CALGB STUDY [J].
AISNER, J ;
WEINBERG, V ;
PERLOFF, M ;
WEISS, R ;
PERRY, M ;
KORZUN, A ;
GINSBERG, S ;
HOLLAND, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1523-1533
[6]  
ALLEGRA JC, 1985, INVEST NEW DRUG, V3, P153
[7]   A PHASE-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH AUTOLOGOUS MARROW SUPPORT IN WOMEN WITH MEASURABLE ADVANCED BREAST-CANCER RESPONDING TO STANDARD-DOSE THERAPY [J].
ANTMAN, K ;
AYASH, L ;
ELIAS, A ;
WHEELER, C ;
HUNT, M ;
EDER, JP ;
TEICHER, BA ;
CRITCHLOW, J ;
BIBBO, J ;
SCHNIPPER, LE ;
FREI, E .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :102-110
[8]  
BONADONNA G, 1984, ADV ANTHRACYCLINE CH, P63
[9]  
BRAMBILLA C, 1986, CANCER TREAT REP, V70, P261
[10]  
BULL JM, 1978, CANCER, V41, P1649, DOI 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO